July 11, 2025 07:00 AM EDT
Peer Review

Sal­ly Sus­man waves good­bye to Pfiz­er; Xaira's new pres­i­dent and COO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Kyle LaHucik

Biotech Correspondent

→ Sal­ly Sus­man will say good­bye to Pfiz­er at the end of 2025, cap­ping an 18-year ca­reer lead­ing the cor­po­rate af­fairs func­tion at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA hands Capri­cor a CRL for its Duchenne cell ther­a­py  

Cen­tu­ry Ther­a­peu­tics lays off half of its staff, CFO de­parts as it nar­rows pri­or­i­ties

FDA's Makary calls for ty­ing fast-re­view vouch­ers to low­er US prices, with­out specifics

As re­searchers come to­geth­er for HIV con­fer­ence, few biotechs can stay the course

Biotech’s Q2 num­bers paint a pic­ture of the good, the bad and the ug­ly

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times